Christopher J. Kirk - 09 Jan 2025 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
CEO, Director
Signature
/s/ Marc Belsky, Attorney-in-Fact
Issuer symbol
KZR
Transactions as of
09 Jan 2025
Net transactions value
$0
Form type
4
Filing time
13 Jan 2025, 16:15:09 UTC
Previous filing
09 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Employee Stock Option (right to buy) Award $0 +120,000 $0.000000 120,000 09 Jan 2025 Common Stock 120,000 $6.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on February 9, 2025, subject to the Reporting Person continuing to provide service through each such date.